The First Crispr Medicine Just Got Approved
by Emily Mullin from on (#6GE4K)
The gene-editing therapy, called Casgevy, uses Crispr to prevent debilitating pain in patients with sickle cell disease. It also eliminates the need for regular blood transfusions in people with beta thalassemia.